Schneider JS - Search Results

1

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W. Schneider JS, et al. J Neurol Sci. 2013 Jan 15;324(1-2):140-8. doi: 10.1016/j.jns.2012.10.024. Epub 2012 Nov 28. J Neurol Sci. 2013. PMID: 23199590 Free PMC article. Clinical Trial.

2

Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.

Schneider JS, Pope A, Simpson K, Taggart J, Smith MG, DiStefano L. Schneider JS, et al. Science. 1992 May 8;256(5058):843-6. doi: 10.1126/science.1350379. Science. 1992. PMID: 1350379

3

Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

Schneider JS. Schneider JS. Neuropharmacology. 1992 Feb;31(2):185-92. doi: 10.1016/0028-3908(92)90030-s. Neuropharmacology. 1992. PMID: 1553028

4

MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.

Schneider JS. Schneider JS. J Neurosci Res. 1992 Jan;31(1):112-9. doi: 10.1002/jnr.490310116. J Neurosci Res. 1992. PMID: 1613817

5

GM1 ganglioside treatment of Parkinson's disease: an open pilot study of safety and efficacy.

Schneider JS, Roeltgen DP, Rothblat DS, Chapas-Crilly J, Seraydarian L, Rao J. Schneider JS, et al. Neurology. 1995 Jun;45(6):1149-54. doi: 10.1212/wnl.45.6.1149. Neurology. 1995. PMID: 7783880 Clinical Trial.

6

LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.

Schneider JS, DiStefano L. Schneider JS, et al. Neuroreport. 1993 Nov 18;5(2):103-4. doi: 10.1097/00001756-199311180-00001. Neuroreport. 1993. PMID: 8110995

7

Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study.

Schneider JS, Roeltgen DP, Mancall EL, Chapas-Crilly J, Rothblat DS, Tatarian GT. Schneider JS, et al. Neurology. 1998 Jun;50(6):1630-6. doi: 10.1212/wnl.50.6.1630. Neurology. 1998. PMID: 9633704 Clinical Trial.

8

Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.

Rothblat DS, Schneider JS. Rothblat DS, et al. Among authors: schneider js. Ann N Y Acad Sci. 1998 Jun 19;845:274-7. doi: 10.1111/j.1749-6632.1998.tb09680.x. Ann N Y Acad Sci. 1998. PMID: 9668361

9

GM1 ganglioside in the treatment of Parkinson's disease.

Schneider JS. Schneider JS. Ann N Y Acad Sci. 1998 Jun 19;845:363-73. doi: 10.1111/j.1749-6632.1998.tb09688.x. Ann N Y Acad Sci. 1998. PMID: 9668369 Clinical Trial.

10

Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation.

Schneider JS, Schroeder JA, Rothblat DS. Schneider JS, et al. Brain Res. 1998 Nov 30;813(1):82-7. doi: 10.1016/s0006-8993(98)01007-5. Brain Res. 1998. PMID: 9824674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters